Loading...
Please wait, while we are loading the content...
Similar Documents
Immunotherapy of hepatocellular carcinoma
| Content Provider | Scilit |
|---|---|
| Author | Pardee, Angela D. Butterfield, Lisa H. |
| Copyright Year | 2012 |
| Description | Current therapies for advanced hepatocellular carcinoma (HCC) are marginally effective and exacerbate underlying liver disease. The ability of immunotherapy to elicit nontoxic, systemic, long-lived anti-tumor activity makes it particularly well-suited for use in the setting of HCC. While therapeutic benefit has been achieved in early clinical trials, the efficacy of immune-based therapies is limited by several unique properties of HCC, most notably the inherently tolerogenic character of the liver in both healthy and diseased (chronically-infected or tumor-bearing) states. Therapeutic regimens that both counteract these immunosuppressive mechanisms and amplify tumor-specific immunity are expected to profoundly improve clinical outcomes for HCC patients. |
| Related Links | https://www.tandfonline.com/doi/pdf/10.4161/onci.1.1.18344?needAccess=true https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376967/pdf |
| Ending Page | 55 |
| Page Count | 8 |
| Starting Page | 48 |
| e-ISSN | 2162402X |
| DOI | 10.4161/onci.1.1.18344 |
| Journal | OncoImmunology |
| Issue Number | 1 |
| Volume Number | 1 |
| Language | English |
| Publisher | Informa UK Limited |
| Publisher Date | 2012-01-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: Oncoimmunology Gastroenterology and Hepatology Alpha-fetoprotein Cancer Vaccine Cirrhosis Combination Therapies Hepatitis Hepatocellular Carcinoma |
| Content Type | Text |
| Resource Type | Article |